(Q36645430)

15 August 2017

1 reference

title

Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms (English)

1 reference

15 August 2017

1 reference

Gary P Anderson

1

1 reference

15 August 2017

publication date

1 October 2006

1 reference

Clinical Reviews in Allergy & Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

31

1 reference

15 August 2017

issue

2-3

1 reference

15 August 2017

page(s)

119-130

1 reference

https://scigraph.springernature.com/pub.10.1385/criai:31:2:119

15 August 2017

exact match

0 references

cites work

Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator

1 reference

12 December 2020

The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol

1 reference

12 December 2020

Is there a problem with inhaled long-acting beta-adrenergic agonists?

1 reference

12 December 2020

Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting

1 reference

12 December 2020

A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma.

1 reference

12 December 2020

A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle

1 reference

12 December 2020

The effects of formoterol on plasma exudation produced by a localized acute inflammatory response to bradykinin in the tracheal mucosa of rats in vivo

1 reference

12 December 2020

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

1 reference

12 December 2020

Abnormalities in airway smooth muscle in fatal asthma. A comparison between trachea and bronchus

1 reference

12 December 2020

Prolonged Protection against Methacholine-induced Bronchoconstriction by the Inhaled β2-Agonist Formoterol

1 reference

12 December 2020

Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects

1 reference

12 December 2020

Salbutamol: a new, selective beta-adrenoceptive receptor stimulant

1 reference

12 December 2020

Biochemical characterization of beta2-adrenergic receptor dimers and oligomers

1 reference

12 December 2020

Formoterol, fenoterol, and salbutamol as partial agonists for relaxation of maximally contracted guinea pig tracheae: comparison of relaxation with receptor binding

1 reference

12 December 2020

Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects

1 reference

12 December 2020

Effect of short- and long-acting beta 2-adrenoceptor agonists on pulmonary beta 2-adrenoceptor expression in human lung

1 reference

12 December 2020

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

1 reference

12 December 2020

Role of phosphoinositide metabolism in human bronchial smooth muscle contraction and in functional antagonism by beta-adrenoceptor agonists

1 reference

12 December 2020

Identification of residues required for ligand binding to the beta-adrenergic receptor

1 reference

12 December 2020

The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange

1 reference

12 December 2020

Why are long-acting beta-adrenoceptor agonists long-acting?

1 reference

12 December 2020

Effects of formoterol (BD 40A), a beta-adrenoceptor stimulant, on isolated guinea-pig lung parenchymal strips and antigen-induced SRS-A release in rats

1 reference

12 December 2020

Evidence that the anti-spasmogenic effect of the beta-adrenoceptor agonist, isoprenaline, on guinea-pig trachealis is not mediated by cyclic AMP-dependent protein kinase

1 reference

12 December 2020

The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta- adrenoceptor agonists

1 reference

12 December 2020

Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor

1 reference

12 December 2020

Differential phosphorylation and dephosphorylation of beta2-adrenoceptor sites Ser262 and Ser355,356.

1 reference

12 December 2020

Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo

1 reference

12 December 2020

The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).

1 reference

12 December 2020

Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties

1 reference

12 December 2020

Highly potent beta-2 sympathomimetics convert to less potent partial agonists as relaxants of guinea pig tracheae maximally contracted by carbachol. Comparison of relaxation with receptor binding and adenylate cyclase stimulation

1 reference

12 December 2020

Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration

1 reference

12 December 2020

Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.

1 reference

12 December 2020

Safety of long-acting beta-agonists--an urgent need to clear the air.

1 reference

12 December 2020

G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase

1 reference

12 December 2020

Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group

1 reference

12 December 2020

The extrapulmonary effects of increasing doses of formoterol in patients with asthma

1 reference

12 December 2020

Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells.

1 reference

12 December 2020

Anti-Allergic Activity of Formoterol, a New Beta-Adrenoceptor Stimulant, and Salbutamol in Human Leukocytes and Human Lung Tissue

1 reference

12 December 2020

Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling

1 reference

12 December 2020

Characterization of tolerance to the anti-leakage effect of formoterol in rat airways

1 reference

12 December 2020

The palmitoylation state of the beta(2)-adrenergic receptor regulates the synergistic action of cyclic AMP-dependent protein kinase and beta-adrenergic receptor kinase involved in its phosphorylation and desensitization

1 reference

12 December 2020

Autoradiographic visualization of beta-adrenoceptor subtypes in human lung

1 reference

12 December 2020

Palmitoylated cysteine 341 modulates phosphorylation of the beta2-adrenergic receptor by the cAMP-dependent protein kinase

1 reference

12 December 2020

Organ culture with proinflammatory cytokines reproduces impairment of the beta-adrenoceptor-mediated relaxation in tracheas of a guinea pig antigen model

1 reference

12 December 2020

Apoptosis in the normal and inflamed airway epithelium: role of zinc in epithelial protection and procaspase-3 regulation

1 reference

12 December 2020

Anti-allergic activities of the beta-adrenoceptor stimulant formoterol (BD 40A)

1 reference

12 December 2020

Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core

1 reference

12 December 2020

Formoterol attenuates neutrophilic airway inflammation in asthma

1 reference

12 December 2020

Several studies have shown salmeterol to be more potent than salbutamol for systemic effects

1 reference

12 December 2020

Differential Effect of Formoterol on Adenosine Monophosphate and Histamine Reactivity in Asthma

1 reference

12 December 2020

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

12 December 2020

Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists

1 reference

12 December 2020

Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation

1 reference

12 December 2020

Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia

1 reference

12 December 2020

Functional rescue of a constitutively desensitized beta2AR through receptor dimerization.

1 reference

12 December 2020

1 reference

12 December 2020

The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol.

1 reference

12 December 2020

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

1 reference

12 December 2020

Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue

1 reference

12 December 2020

Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer

1 reference

12 December 2020

Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor

1 reference

12 December 2020

Mutational analysis of beta-adrenergic receptor glycosylation

1 reference

12 December 2020

Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients

1 reference

12 December 2020

Identification of an allosteric binding site for Zn2+ on the beta2 adrenergic receptor

1 reference

12 December 2020

Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis.

1 reference

12 December 2020

A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins

1 reference

12 December 2020

Structural features required for ligand binding to the beta-adrenergic receptor

1 reference

12 December 2020

Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol

1 reference

12 December 2020

Beta-adrenoceptors on smooth muscle, nerves and inflammatory cells

1 reference

12 December 2020

Localisation and expression of beta-adrenoceptor subtype mRNAs in human lung

1 reference

12 December 2020

Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility

1 reference

12 December 2020

Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration

1 reference

12 December 2020

The pharmacology of salmeterol

1 reference

12 December 2020

Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma

1 reference

12 December 2020

Safety and tolerability of high-dose formoterol (Aerolizer) and salbutamol (pMDI) in patients with mild/moderate, persistent asthma

1 reference

12 December 2020

Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy

1 reference

12 December 2020

Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids

1 reference

12 December 2020

Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox

1 reference

12 December 2020

Long- and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi

1 reference

12 December 2020

Identifiers

DOI

10.1385/CRIAI:31:2:119

1 reference

Dimensions Publication ID

15 August 2017

1013396589

0 references

1 reference